Related Experiment Video

Updated: Aug 14, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Acute myocardial infarction in a patient with essential thrombocythemia who underwent successful stenting--a case

Tomonori Watanabe1, Hiroyuki Fujinaga, Yasumasa Ikeda

  • 1Department of Cardiology, Tokushima Prefectural Central Hospital, Tokushima, Japan. wtomo@par.odn.ne.jp

Angiology
|December 6, 2005
PubMed

Insights

Essential thrombocythemia (ET) rarely causes coronary artery thrombosis. This case highlights acute myocardial infarction (MI) due to ET, successfully treated with angioplasty and stenting.

Area of Science:

  • Cardiology
  • Hematology

Background:

  • Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by elevated platelet counts.
  • ET can lead to systemic vascular thrombosis, but coronary artery involvement is uncommon.

Observation:

  • A 67-year-old male with ET presented with severe chest pain.
  • Coronary angiography revealed subtotal thrombotic occlusion of the left main trunk (LMT) coronary artery.

Findings:

  • Successful coronary angioplasty and stenting were performed for the LMT occlusion.
  • Follow-up angiography showed no significant restenosis after 4 weeks.

Implications:

  • This case underscores the rare but serious risk of acute myocardial infarction in ET patients.
  • Coronary stenting and antiplatelet therapy can be effective in managing ET-related coronary thrombosis.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...